Wilfried Moreira

Dr. Wilfried Moreira

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2025 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
YLYang Liu
Yang Liu
STShuhua Thong
Shuhua Thong
WMWilfried Moreira
Wilfried Moreira
JYJia Hao Yeo
Jia Hao Yeo
YZYang Zhong
Yang Zhong
AKAndrea Lay-Hoon Kwa
Andrea Lay-Hoon Kwa

Verified
Journal Article
Open access
PDF file
PHPeiying Ho
Peiying Ho
LDLinh Chi Dam
Linh Chi Dam
WKWei Ren Ryanna Koh
Wei Ren Ryanna Koh
RNRui Si Nai
Rui Si Nai
QNQian Hui Nah
Qian Hui Nah
WMWilfried Moreira
Wilfried Moreira
Multidrug-resistant P. aeruginosa infections pose a serious public health threat due to the rise in antimicrobial resistance. Phage therapy has emerged as a promising alternative. However, P. aeruginosa has evolved various mechanisms to thwart phage attacks, making it crucial to decipher these resistance mechanisms to develop effective therapeutic strategies. In this study, we conducted a forward-genetic screen of the P. aeruginosa PA14 non-redundant transposon library (PA14NR) to identify dominant-negative mutants displaying phage-resistant phenotypes. Our screening process revealed 78 mutants capable of thriving in the presence of phages, with 23 of them carrying insertions in genes associated with membrane composition. Six mutants exhibited total resistance to phage infection. Transposon insertions were found in genes known to be linked to phage-resistance such as galU and a glycosyl transferase gene, as well as novel genes such as mexB, lasB, and two hypothetical proteins. Functional experiments demonstrated that these genes played pivotal roles in phage adsorption and biofilm formation, indicating that altering the bacterial membrane composition commonly leads to phage resistance in P. aeruginosa. Importantly, these mutants displayed phenotypic trade-offs, as their resistance to phages inversely affected antibiotic resistance and hindered biofilm formation, shedding light on the complex interplay between phage susceptibility and bacterial fitness. This study highlights the potential of transposon mutant libraries and forward-genetic screens in identifying key genes involved in phage-host interactions and resistance mechanisms. These findings support the development of innovative strategies for combating antibiotic-resistant pathogens.

9 January 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
JCJasmine Jasmine Chung
Jasmine Jasmine Chung
YLYang Liu
Yang Liu
STShuhua Thong
Shuhua Thong
YZYang Zhong
Yang Zhong
ZCZhi Soon Chong
Zhi Soon Chong
AKAndrea Lay-Hoon Kwa
Andrea Lay-Hoon Kwa
Biofilm-related vascular graft infections (VGIs) pose major therapeutic challenges due to persistent, antibiotic-resistant bacteria often residing in retained grafts. Phage therapy offers a promising alternative treatment strategy against biofilm-associated infections, though its use remains mostly ad hoc and typically considered a last-resort intervention. We report here the treatment of a refractory, fluoroquinolone non-susceptible Pseudomonas aeruginosa VGI using a systematically planned and synergistic phage-antibiotic combination approach. Adjunctive phage therapy led to radiological improvement, as seen by reduced 18F-FDG PET/CT tracer uptake around the graft. The patient was transitioned to oral fluoroquinolone suppression therapy with no recurrence of bacteremia to-date, after a year. Our workflow led to the selection of phages that sensitized Pseudomonas aeruginosa to killing by levofloxacin and piperacillin-tazobactam. We established that this phage-driven antibiotic sensitization was due to the ability of our phages to use the MexAB-OprM efflux pump as a receptor. We also showed that our phages had potent anti-biofilm activity. We advocate a systematic, multi-pronged management strategy for refractory VGIs, including early therapeutic drug monitoring (TDM), in vitro antibiotic combination testing (iACT), and timely adjunctive phage therapy. This case illustrates the utility of individualized, strategic approaches and highlights adjunctive phage therapy’s potential in treating complex biofilm-related infections.

18 March 2022 in PHAGE: Therapy, Applications, and Research
Verified
Journal Article
Closed access
NVNavin Kumar Verma
Navin Kumar Verma
STSi Jia Tan
Si Jia Tan
JCJohn Chen
John Chen
HCHanrong Chen
Hanrong Chen
MIMuhammad Hafiz Ismail
Muhammad Hafiz Ismail
MSMaurice A.M. van Steensel
Maurice A.M. van Steensel
Bacteriophages and phage-derived proteins are a promising class of antibacterial agents that experience a growing worldwide interest. To map ongoing phage research in Singapore and neighboring countries, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore (NTU) and Yong Loo Lin School of Medicine, National University of Singapore (NUS) recently co-organized a virtual symposium on Bacteriophage and Bacteriophage-Derived Technologies, which was attended by more than 80 participants. Topics were discussed relating to phage life cycles, diversity, the roles of phages in biofilms and the human gut microbiome, engineered phage lysins to combat polymicrobial infections in wounds, and the challenges and prospects of clinical phage therapy. This perspective summarizes major points discussed during the symposium and new perceptions that emerged after the panel discussion.